Announcement on the Change of Spokesperson

Announcement of New CEO
July 22, 2019
Subsidiary AP Biosciences and Tasly Biopharmaceuticals Signed Cooperative Development and Authorized Agreement of New Antibody Drug
July 29, 2019
  1. Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, company secretary, research and development officer, or internal audit officer): Spokesperson
  2. Date of occurrence of the change: Jul 22, 2019
  3. Name, title, and resume of the replaced person: Amy Huang, General Manager
  4. Name, title, and resume of the replacement: Michael Chang, the chairman and CEO
  5. Type of the change (please enter: “resignation”, “position adjustment”,“dismissal”, “retirement”, “death” or “new replacement” ): Position adjustment
  6. Reason for the change: Chairman holds concurrently, agreed by Board of directors
  7. Effective date: Aug 01, 2019
  8. Contact telephone number of the replacement: (02)2655-8799
  9. Any other matters that need to be specified: None